Castration Resistant Prostatic Neoplasms
6 clinical trials · Condition
◉ Watch Castration Resistant Prostatic Neoplasms
| Record | Firm | Date |
|---|---|---|
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NCT05252390) | Nuvation Bio Inc. | 2022-03-29 |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors (NCT04541225) | Nuvation Bio Inc. | 2020-12-08 |
| Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer (NCT04381832) | Arcus Biosciences, Inc. | 2020-07-07 |
| A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (NCT03551782) | Janssen Research & Development, LLC | 2018-06-28 |
Track Castration Resistant Prostatic Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.